I agree that this site is using cookies. You can find further informations here.
X
Gasink, Christopher
84  results:
Search for persons X
?
1

FRI-023 Effect of obeticholic acid on reduction and normali..:

Gish, Robert G. ; Wheeler, Darren ; Li, Jing..
Journal of Hepatology.  80 (2024)  - p. S625-S626 , 2024
Link: https://doi.org/10.1016/..
 
?
2

FRI-008 Association of elevated liver biochemistries and cl..:

Victor III, David W. ; MacEwan, Joanna P. ; Hernandez, Jennifer...
Journal of Hepatology.  80 (2024)  - p. S621 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled..:

Ghosh, Subrata ; Feagan, Brian G ; Ott, Elyssa...
Journal of Crohn's and Colitis.  , 2024
Link: https://doi.org/10.1093/..
 
?
4

FRI-015 Stabilization of enhanced liver fibrosis and liver ..:

Gish, Robert G. ; Wheeler, Darren ; Li, Jing..
Journal of Hepatology.  80 (2024)  - p. S623 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Evolution of Symptoms After Ustekinumab Induction Therapy i..:

Colombel, Jean-Frédéric ; Sands, Bruce E. ; Gasink, Christopher...
Clinical Gastroenterology and Hepatology.  22 (2024)  1 - p. 144-153.e2 , 2024
Link: https://doi.org/10.1016/..
 
?
6

FRI-030 Evaluation of aspartate aminotransferase to platele..:

Bonder, Alan ; Wheeler, Darren ; Li, Jing..
Journal of Hepatology.  80 (2024)  - p. S627-S628 , 2024
Link: https://doi.org/10.1016/..
 
?
7

THU-132 Obeticholic acid normalizes inflammatory biomarkers..:

Jones, David E. ; Bowlus, Christopher L. ; Thranian, Arash...
Journal of Hepatology.  80 (2024)  - p. S325 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Mo1743 SAFETY OF USTEKINUMAB IN IBD: FINAL POOLED LONG-TERM..:

Sands, Bruce E. ; Feagan, Brian G. ; Ott, Elyssa...
Gastroenterology.  164 (2023)  6 - p. S-889 , 2023
Link: https://doi.org/10.1016/..
 
?
9

1027 EFFICACY AND SAFETY OF INTRAVENOUS USTEKINUMAB REINDUC..:

Lee, Scott D. ; Schreiber, Stefan ; Van Der Woude, Christien Janneke...
Gastroenterology.  164 (2023)  6 - p. S-220-S-221 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Significant dose-dependent reduction in liver stiffness usi..:

Loomba, Rohit ; Anstee, Quentin ; Harrison, Stephen...
Journal of Hepatology.  78 (2023)  - p. S647-S648 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Evaluation of non-invasive tests to identify precirrhotic f..:

Loomba, Rohit ; Kowdley, Kris ; Anstee, Quentin...
Journal of Hepatology.  78 (2023)  - p. S118 , 2023
Link: https://doi.org/10.1016/..
 
?
12

HLA-DQA1*05 Not Associated With Ustekinumab Loss of Respons..:

Colombel, Jean-Frédéric ; Martín-Arranz, María D ; Brinkman, Brigitta...
Inflammatory Bowel Diseases.  , 2023
Link: https://doi.org/10.1093/..
 
?
13

Five-Year Efficacy and Safety of Ustekinumab Treatment in C..:

Sandborn, William J. ; Rebuck, Rory ; Wang, Yuhua...
Clinical Gastroenterology and Hepatology.  20 (2022)  3 - p. 578-590.e4 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Mo1479: PERIANAL FISTULA CLOSURE IN PATIENTS RECEIVING USTE..:

Sands, Bruce E. ; Panaccione, Remo ; Gasink, Christopher...
Gastroenterology.  162 (2022)  7 - p. S-782 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Ustekinumab versus adalimumab for induction and maintenance..:

Sands, Bruce E ; Irving, Peter M ; Hoops, Timothy...
The Lancet.  399 (2022)  10342 - p. 2200-2211 , 2022
Link: https://doi.org/10.1016/..
 
1-15